Latest News

Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill
Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill

July 17th 2025

Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.

FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years

July 10th 2025

New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies / Image credit: ©Ezume Images/AdobeStock
New Data at IAS 2025 Underscore Real-World Success of Long-Acting Injectable HIV Therapies

July 8th 2025

Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds
Clinic- and System-Level Factors Drive Racial Disparities in COVID-19 Antiviral Prescribing, Study Finds

July 7th 2025

Image courtesy of Cincinnati Children's
Intranasal COVID-19 Vaccine Found Safe and Immunogenic in Open Label Phase 1 Clinical Trial

July 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.